Hassan, Abbas M.
Nguyen, Huan T.
Corkum, Joseph P.
Liu, Jun
Kapur, Sahil K.
Chu, Carrie K.
Tamirisa, Nina
Offodile, Anaeze C. 2nd
Article History
Received: 15 June 2022
Accepted: 18 August 2022
First Online: 9 September 2022
Disclosure
: Dr. Offodile reports research funding from Blue Cross Blue Shield Affordability Cures Research Consortium, University Cancer Foundation, Rising Tide Foundation for Clinical Cancer Research, and the National Academy of Medicine. Dr. Offodile also is an unpaid board member of the Patient Advocate Foundation and reports honorarium from the Indiana University and University of Tennessee. All are unrelated to the submitted work. The other authors have no financial or non-financial disclosures.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: This is an observational study, and The University of Texas MD Anderson Cancer waived informed consent.